KP Tissue Releases Fourth Quarter and Full Year 2017 Financial Results
KPLP Q4 2017 Financial Results: Revenue in Q4 2017 was $340.0 million, compared to $339.6 million in Q4 2016, an increase of $0.4 million or 0.1%. The increase in revenue was primarily due to a selling price increase in Canada, offset by lower Consumer sales volume in Canada and the unfavourable impact of foreign exchange on U.S. dollar sales. Net loss in Q4 2017 was $18.0 million, compared to $4.5 million in Q4 2016, primarily due to lower Adjusted EBITDA of $9.2 million, an increase in tax expense of $5.8 million, a decrease in the gain on sale of non-financial assets of $2.5 million and a change in fair value of derivatives of $0.4 million in Q4 2017. These items were partially offset by a decrease in the change in amortized cost of Partnership units liability of $3.3 million and lower depreciation expense of $0.5 million. Click Read More below for additional information.